topographic linkage inside pancreatic carcinomas as well as inside PanINs. Additionally, a topographic and significant association of these markers with nodal status (PDX-1, Ptc, Gli-1), tumor size (PDX-1, Gli-1) and R status (PDX-1) was found. After stratification with the strongest outcome predictor, grading, survival analysis revealed that Ptc expression in grade 2 and PDX-1 expression in grade 3 carcinomas are independent survival factors. Conclusions: Markers of pancreas development are reexpressed in invasive ductal adenocarcinomas and their expression is essentially associated with general clinical and pathological features such as survival or nodal status.
genesis in the context of carcinogenesis [4, 5] . There is a large body of literature dealing with the expression of pancreas duodenum homeobox 1 (PDX-1) and Sonic hedgehog (SHH) proteins during gastrointestinal development in different species, and various knockout models emphasized the importance of the regulation of these embryological markers during morphogenesis [6] [7] [8] [9] . The role of PDX-1 and of members of the hedgehog family such as SHH, the Patched (Ptc) receptor and the transcription factor Gli-1 was pointed out, especially in the pancreas, in the context of endocrine development, regeneration and possible recruitment of stem-cell-like precursor cells during chronic autoimmune and inflammatory destructive pancreatitis [10] [11] [12] [13] [14] . Recently, the role of stem cells and reexpression of stem-cell-like factors (e.g. PDX-1 and SHH) has been demonstrated during cancer development [15] [16] [17] . In this study, we examined if and to what extent and according to what distribution pattern PDX-1, SHH, Ptc and Gli-1 were expressed in human pancreatic ductal cancer (with and without node positivity) and pancreatic intraepithelial neoplasia (PanIN) specimens of a well-defined patient group. Furthermore, we investigated if their presence influences therapeutic responsiveness and overall survival times.
Materials and Methods
All samples were obtained from the archives of the Department of Pathology of the University of Erlangen-Nuremberg. All tissues were studied in an anonymous fashion, in accordance with the recommendations of the local ethics research committee. Furthermore, the analysis did not extend to examination of individual case records. Only patients with complete follow-up data (including standard risk factors [18, 19] ) were considered. Surgical specimens from patients with invasive ductal adenocarcinoma of the pancreas (UICC pT3 pN0 or pT3pN1) who underwent tumor resection between 1998 and 2004 had been obtained during routine surgery and embedded in paraffin. To assess the role of embryonic differentiation markers on response to neoadjuvant chemotherapy (5-fluorouracil/folic acid and gemcitabine), another group of patients was investigated and analyzed as described.
Immunohistochemistry
Immunohistochemical staining procedures were applied as described before [20] . 5-m sections were deparaffinized using graded alcohols. After microwave antigen retrieval (MW) (10 mmol/l citrate buffer, pH 6.0; 8 min at 560 W and 8 min at 800 W) or trypsin, the sections were incubated overnight using antibodies specific for PDX-1 (rabbit polyclonal antibody, dilution 1: 250, MW, Chemicon, Temecula, Calif., USA), SHH (goat polyclonal antibody, 1: 100, MW, Santa Cruz Biotechnology, Santa Cruz, Calif., USA), Ptc (goat polyclonal antibody, 1: 100, trypsin, Santa Cruz Biotechnology), Gli-1 (goat polyclonal antibody, 1: 200, MW, Santa Cruz Biotechnology), Ki-67 (mouse monoclonal antibody, 1: 500, MW, Dako, Glostrup, Denmark) and p53 (mouse monoclonal antibody, 1: 1,000, MW, Dako). Next, depending on the primary antibody, biotinylated rabbit-anti-goat or goat-anti-rabbit (Dako) antibodies were applied on the sections. Detection was done using Dako's streptavidin-biotin complex and alkaline phosphatase system, following their user's manual. The sections were developed using Fast Red (Sigma, Germany) or diaminobenzidine (DAB; Roche Molecular Biochemicals, Mannheim, Germany). Nuclei were counterstained with hematoxylin.
Morphological Pattern Analysis and Quantization of Stained Material
The stained sections were viewed by a blinded independent pathologist and representative images were taken from 4 highpower fields (400 ! magnification) in each section. Intensity of expression levels was characterized using the following scheme: negative (-), weak (+), moderate (++), strong (+++), differing focal expression being indicated in round brackets. Additionally, the percentage of positive cells per high-power field was determined using ImageAccess Enterprise 5 software (Imagic Bildverarbeitung, Glattbrugg, Switzerland). For further statistical analysis, the calculated product of intensity and extensity was used. The distribution of PDX-1, SHH, Gli-1, and Ptc was compared with the morphological patterns of the pancreatic carcinoma (separately for tumor front and tumor center) and PanIN as well as with reactive response of normal pancreatic tissue [21, 22] . Because of the small size of PanIN lesions, only intensity measurement was statistically analyzed for PanIN. Although many heterogeneous target genes of PDX-1 and of members of the hedgehog family were described, most of them are associated with cell cycle or cell growth and death [23] [24] [25] . Therefore, we investigated the expression extensity of Ki-67 and p53 in the front and center areas of the tumor.
Statistical Analysis
For univariate analysis between different subgroups, the MannWhitney U test was used. Correlation coefficients were calculated according to Pearson and Kendall. Patient survival was estimated by the Kaplan-Meier method comparing the survival curves with the log-rank test; the correlation of sets of variables was determined in a multivariate analysis with the Cox proportional hazards model [26] . All tests were two-tailed. A p value of less than 0.05 was considered statistically significant. All statistical analyses were performed using SPSS 14 (SPSS Inc., Chicago, Ill., USA).
Results

Analysis of the General Pathologic Features
Patients' main characteristics are listed in table 1 . In short, the pT3pN0, pT3pN1, ypTypn0 and ypTypN1 groups consisted of 13, 25, 7 and 6 patients, respectively. Patient populations in the nonchemotherapy groups (node-positive vs. node-negative) were adequately matched and did not show any statistically significant differences in gender, age, R status and tumor size. Grading was significantly higher in node-positive (G2/G3 = 10/15) compared to node-negative patients (G2/G3 = 10/3; 2 test, p ! 0.05).
Distribution Pattern of PDX-1-and Hedgehog-Expression Depending on Nodal Status and Preoperative Chemotherapy
Overall, the mean expression rate of all investigated proteins was weak and the highest expression was observed for PDX-1 compared to proteins of the hedgehog signaling cascade. In detail, the expression level of PDX-1 in the tumor front was significantly lower in the pT3N0 sections than in pT3N1 sections; it was also significantly higher in the tumor center of pT3N0 than pT3N1 sections (Mann-Whitney U test, p ! 0.05; table 2 ). SHH expression was low and statistically independent of nodal status or localization inside the tumor. Similarly, Ptc and Gli-1 expression was low but significantly higher at the tumor front (Ptc/Gli-1) and tumor center (Gli-1) in the pT3N1 sections than pT3N0 (see table 2 ). In the ypN0/ypN1 sections, the expression of all embryonic markers was significantly lower (negative to very low) compared to the nontreated group (Mann-Whitney U test, p ! 0.05) with the higher expression levels of PDX-1 comparable to those of the nontreated group. Interestingly, no signal of SHH, Ptc and Gli-1 was observed in the tumor center of ypN0/ pN1 sections. Compared to the expression of PDX-1, SHH, Ptc and Gli-1, the extensity of Ki-67 and p53 was continuously higher at the tumor front than in the tumor center, independent of the pretreatment status ( table 2 ) with significantly higher levels in the nontreated compared to the treated group (Mann-Whitney U test, p ! 0.05). In relation to morphologic structures, expression of PDX-1 was found to be distinctive and to be present to a greater extent in ductal tumor formations than in solid formations ( fig. 1 , 2 
Correlation Analysis of PDX-1 and Hedgehog Signaling Cascade with General Pathologic Features
Correlation analysis revealed a significant negative correlation between PDX-1 expression at the tumor center and nodal status (r = -0.641, p ! 0.001) and a significant positive correlation with tumor size (r = 0.499, p ! 0.001) in patients not treated with chemotherapy. On the other hand, a significant positive correlation was established between PDX-1 expression at the tumor front and grading as well as R status (r 1 0.771, p ! 0.05) and PDX-1 expression in the tumor center and tumor size (r = 0.713, p ! 0.05) in chemotherapy-treated patients. In the hedgehog signaling cascade, a significant positive correlation was found between Ptc and Gli-1 expression at the tumor front and nodal status in patients not treated with chemotherapy (r 1 0.760, p ! 0.01). Additionally, expression of Ptc at the tumor front was significantly associated with tumor size in chemotherapy-treated patients (r = 0.818, p ! 0.05).
Compared to the extensity of Ki-67 and p53, we found a significant association of PDX-1 expression with Ki-67 at the tumor front and with p53 at the tumor center (r 1 0.478, p ! 0.05) as well as of Gli-1 expression with p53 at the tumor center (r = 0.518, p = 0.04), whereas SHH and Ptc were usually (p 1 0.05) linked to expression of Ki-67 and p53. Interestingly, besides a significant positive association of Ki67 at the tumor center with tumor size (r = 0.597, p = 0.03), other pathological features only tended to be positively linked to the expression of Ki-67 and p53.
Correlation of Gene Expression Levels with Grade of PanINs
Overall, the expression of all proteins correlated significantly with the grade of PanINs (Spearman's correlation analysis, r 1 0.98, p ! 0.01). The expression levels were comparable with the invasive tumor compartments: . Ptc and Gli-1 were predominantly expressed at the tumor center ( M , N ) whereas PDX-1 was found at the tumor front, predominantly in association with ductal tumor formations ( L ). Expression of Ptc ( P , 400 ! ) and Gli-1 ( Q , 400 ! , arrows) in typical ductal tumor formation at the tumor center (of I , dotted square) was associated with strong expression of p53 ( R , 400 ! ). 
Survival Time Analysis
The mean expression rate of PDX-1, Shh, Ptc and Gli-1 as well as of Ki-67 and p53 in tumor center and front was calculated for further time-dependent statistical analysis and divided into low and high expression rates according to mean expression level. Age, sex, grading, nodal status (N0 versus N1), tumor size, R status and preoperative chemotherapy were used for the Cox-regression analysis. Only grading was identified as a factor significantly influencing survival (Wald ( fig. 4 A) . The expression patterns of the analyzed proteins did not additionally influence patient survival. Therefore, a stratification of the patients according to tumor grading was done. Using this model, the Kaplan-Meier analysis identified the expression of PDX-1 at the tumor front in the grade 3 subgroup and Ptc expression in the tumor center of the grade 2 subgroup as predictive prognostic factors. PDX-1 expression at the tumor front had a significant negative influence on survival in grade 3 pancreatic carcinomas (Logistic Rank Test (Mantel Cox) p = 0.05; fig. 4 C) , whereas higher expression of Ptc at the tumor center was associated with better outcome in grade 2 pancreatic carcinomas (Logistic Rank Test (Mantel Cox) p = 0.03; fig. 4 B, C). All additionally performed sum scores of PDX-1, SHH, Ptc and Gli-1 as well as of Ki-67 and p53 had no significant impact on the survival time. This was also evident for the expression of these proteins in PanINs also in circumstances of recoding in low and high expression.
Discussion
The main findings of our investigation are summarized as follows: (1) Our study complemented what was already known about the expression of embryonic markers like PDX-1, SHH, Ptc and Gli-1 in pancreatic cancer and its precursor lesions [15] [16] [17] . We have shown the exact expression levels at different localizations within the tumor, i.e. enhanced expression of these markers in ductal tumor formations (assessed separately for tumor front and center) and in adjacent fibrotic and atrophic tissue. Mainly PDX-1 and to a lower extent SHH, Ptc and Gli-1 were detected in the human pancreatic carcinoma specimens. In contrast to the linear PDX-1 expression inside PanINs, hedgehog family members showed a stepwise black-or- white expression pattern comparable to findings in intraductal papillary mucinous tumors, which are putative pancreatic cancer precursor lesions, too [27] . This indicates that embryonic markers of morphogenesis are associated with the grade and progression of PanINs similarly to classical markers of proliferation and differentiation [28] . Interestingly, the expression pattern was heterogeneous in invasive carcinomas: we found a higher expression of hedgehog members (especially Ptc) at the tumor front and in the center in nontreated nodal-positive cases than in nontreated nodal-negative cases. In contrast, the distribution of PDX-1 was the same as that of the hedgehog proteins at the tumor front but differed in the tumor center. Although Gli proteins are known nuclear transcription factors, they are also part of the cytoplasmic signal transduction pathway of SHH via its membranous receptor Ptc and the Smoothend (SMO) regulator [29] , which is in line with our results showing (predominant) cytoplasmic and nuclear expression of Gli-1. While the regulation of cytoplasmic to nucleus shuttling is well described for the Drosophila homologue of Gli, cubitus interruptus (Ci), this mechanism is not completely understood in vertebrates [30] . In the cytoplasm and in the absence of SHH, Gli usually forms a complex with several regulatory protein kinases, e.g. Fused (Fu), Suppressor of Fused (Sufu) and others like protein kinase A (PKA), glycogen synthase kinase 3 (GSK3) or casein kinase 1 (CK1) [31] , indicating that Gli has more functions in pancreatic carcinogenesis than just mediating the hedgehog signaling pathway (for a detailed review, see [14] ). Our results show an overall low activity of the SHH pathway, especially in the tumor center, which explains the predominant cytoplasmic staining of Gli-1 in these cases. During embryonic development, SHH repression in the foregut endoderm leads to the activation of the homeobox transcription factor PDX-1 in the pancreatic bud [32] . While PDX-1 expression is restricted to ␤ -cells in the normal adult pancreas, reactivation can occur by inflammation, regeneration and tumor formation already in early precursor lesions like PanIN [33] . Several studies have shown that PDX-1 is expressed in up to 50% of pancreatic ductal adenocarcinomas and correlated with staging, lymph node status, proliferation index and prognosis [34, 35] . Although a nuclear expression of the transcription factor PDX-1 has been repeatedly demonstrated in pancreatic ␤ -cells, we and others found a predominant cytoplasmic localization in the investigated pancreatic ductal adenocarcinomas. In endocrine cells, the nucleo-cytoplasmatic translocation of PDX-1 has been shown to be regulated by glucose metabolism, oxidative stress and subsequent activation of the c-Jun Nterminal kinase (JNK) pathway [36, 37] . Interestingly, gemcitabine, which was included in the standard chemotherapy regimen of our patients, has been shown to induce apoptosis also via the JNK pathway [38, 39] and may thus contribute to the cytoplasmic localization of PDX-1 found in our study. Other factors regulating the nuclear translocation of PDX-1 include signaling through phosphatidylinositol 3-kinase (PI3K) [40, 41] or posttranscriptional modifications as ubiquitination or sumoylation [42] , which have not yet been confirmed in clinical specimens of pancreatic ductal adenocarcinoma. We previously identified two major morphologic and molecular pathways in human pancreatic cancer cell lines using xenograft models: A ductal tumor pattern with predominance of CK7 and PDX-1 and a more differentiated solid tumor pattern with increased expression of CK8 and SHH/Ptc [43] . As our patients were treated for invasive ductal adenocarcioma, we expected and confirmed a ductal morphology with low levels of SHH but with higher levels of PDX-1. Additionally, the expression levels of hedgehog proteins like SHH, Ptc and Gli-1 was reduced under preoperative chemotherapy as in our own epigenetic studies, indicating the relevance of analyzing the expression pattern of these embryonic markers for further therapeutic interventions [44] . Looking in detail at tumor compartments, previous studies have shown that proliferation, which occurs predominantly at the tumor front, is dependent on SHH expression in pancreas cancer [35] . In vitro experiments demonstrated that downregulation of the hedgehog pathway through siRNA or cyclopamine is essentially associated with a strongly reduced proliferation activity [17, 45] . These observations were made in other types of human cancer as well. In colorectal adenocarcinoma, SHH and the expression of its downstream signaling components Gli-1 and FOXM1 were markedly increased compared to normal colonic tissue [46] . The same findings could be confirmed in the colon adenocarcinoma-derived cell line HT-29: Here, exogenic SHH stimulation increased proliferation and was abrogated by treatment with cyclopamine or specific anti-SHH-antibodies. This further exemplifies that a subset of cells (i.e. SHH-positive cells) at the tumor front might be responsible for proliferation and invasion of the tumor and possesses early developmental or stem-celllike properties [47] . Another study identified a subtype of cells in pancreatic cancer termed 'pancreatic cancer stem cells' for their ability of self-renewal, of producing differentiated progeny and increased expression of the developmental signaling molecule SHH, properties usually shared with stem cells [48] . These findings suggest that the capability of a tumor to grow and propagate is dependent on this stem-cell-like subtype within the tumor itself. The number of these subsets of cells, which are positive for the surface markers CD44, CD24 and ESA is quantified at 0.2-0.8% of the total pancreatic cancer cells. SHH expression in this subset of cells was upregulated 46-fold compared to normal pancreatic epithelial cells, while SHH expression in bulk pancreatic cancer cells was upregulated 4-fold compared to normal pancreatic epithelial cells. It is therefore possible that the increased expression of SHH at only some cells at the tumor front in our samples could be attributed to this subset of pancreatic cancer cells. Using microarray investigations, it was shown that the gene and protein expression pattern depends significantly on the localization inside pancreatic cancer [49] . Our results showed that a higher proliferation index (determined by Ki-67 immunohistochemistry) is found at the tumor front and in chemotherapy-naive specimens and that Ki-67 is strongly associated with PDX-1 expression at this location. Our results thus confirm findings in ovarian carcinomas showing a positive association between cell proliferation (as measured by Ki-67 positivity) in vivo and embryonic marker gene expression [50] . Interestingly, p53 expression was also associated with Ki-67 expression at both sites and with both PDX-1 and Gli-1 only at the tumor center. These findings indicate differential roles of p53 during pancreatic cancer formation and progression; further studies are needed to address this issue.
Our findings show a differential association of the investigated markers with the patients' clinico-pathological features. While nodal-negative cases are associated with PDX-1, nodal-positive cases are linked to Ptc and Gli-1 expression, indicating that different molecular mechanism of embryonic markers are involved in the development of nodal metastasis. Interestingly, another investigation found a completely different association of PDX-1 expression and nodal status which could be caused by the heterogeneous patient group (e.g. all UICC stages) as well as by the fact that we analyzed the whole and not the topographical expression pattern inside pancreatic tumors [35] . Using a survival analysis, classical grading was a negative predictor of outcome [18] . Interestingly, after stratification with grading, PDX-1 and Ptc were also predictors of outcome. Especially the negative predictor-PDX-1 is comparable to earlier findings. Koizumi et al. [34] showed that the survival of PDX-1-positive patients was poorer than that of PDX-1-negative patients On the other hand, upregulation of the hedgehog ligand receptor Ptc could be identified as a positive predictive marker of patient outcome and was in line with the study of Liu et al. [51] showing reduced expression in cases with poorly differentiated cancer. Taken together, these findings support that morphologic and molecular patterning inside of the heterogeneous tumor compartments is involved in tumor progression and clinical outcome. Although we investigated a relatively homogeneous group of invasive ductal adenocarcinomas of the pancreas in our study, the findings must be considered with caution considering the small number of patients (especially of pretreated cases), which limits the power of our study. Additional prospective studies are needed to confirm our findings and establish these embryonic marker genes as potential new biomarkers of pancreatic cancer.
